Do you want to read an article? Please log in or register.
Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.
Related content
Aging and Cognitive FunctionsParkinson’s Disease
Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial
Neurology.
Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE
doi: 10.1212/
RECOMMENDED
Parkinson’s Disease
Diagnosis and Treatment of Parkinson Disease: A Review
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
JAMA.
Armstrong MJ, Okun MS
doi: 10.1001/jama.2019.22360.
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Lancet Neurol.
Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A
doi: 10.1016/S1474-
Predicting progression in patients with Parkinson's disease
Lancet Neurol.
Blauwendraat C, Bandrés-Ciga S, Singleton AB
doi: 10.1016/
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation
Lancet Neurol.
Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS
doi: 10.1016/
Parkinson’s DiseaseAnxiety and Depression
Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study
Lancet Neurol.
Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA
doi: 10.1016/
RECOMMENDED
Parkinson’s Disease
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Mov Disord.
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee
doi: 10.1002/mds.27602.
RECOMMENDED
Parkinson’s Disease
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease
Parkinsonism Relat Disord.
Contin M, Lopane G, Mohamed S, Calandra-Buonaura G, Capellari S, De Massis P, Nassetti S, Perrone A, Riva R, Sambati L, Scaglione C, Cortelli P
doi: 10.1016/j.parkreldis.
Psychosis and Schizophrenia
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease
Behav Neurol.
Divac N, Stojanović R, Savić Vujović K, Medić B, Damjanović A,
Prostran M
doi: 10.1155/2016/4938154.